260 results
Page 5 of 13
8-K
EX-99.1
wxfkkbbwbc9iygyt6
14 Dec 20
Regulation FD Disclosure
8:04am
8-K
EX-99.2
qtmwmboto3aeq8di2jg
14 Dec 20
Regulation FD Disclosure
8:04am
8-K
EX-99.1
yi0o djm2ax
5 Nov 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results
4:09pm
424B3
qqt4joyv mmgreyfwuk6
2 Sep 20
Prospectus supplement
4:03pm
8-K
EX-99.1
yryw298w6
13 Aug 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Second Quarter Financial Results
4:08pm
8-K
EX-10.1
3b2gxhghc rx79b2
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
424B3
pfqnj1g29lrjs18ju
29 Jun 20
Prospectus supplement
12:00am
424B5
rfdas
26 May 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-10.1
m5ldzf
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
424B5
qqn8s780 ai4shcp7
27 Apr 20
Prospectus supplement for primary offering
7:30am
8-K
EX-10.1
8p6wayi8
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-99.2
tuw odb04zgqlaam96
5 Mar 20
Caladrius Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:07pm
8-K
EX-99.2
7dw0ab8f
18 Nov 19
Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019
6:21am